FCF Fox Corporate Finance supports Quantum-Systems in Venture Debt Financing
Munich-based drone specialist concludes loan agreement with European Investment Bank (EIB) FCF analyses needs and finds optimal financing solution Munich, July 19th, 2021 – Munich-based financing specialist FCF Fox Corporate Finance GmbH acted as corporate
FCF Automotive Supplier Market Study – 2021 published
FCF Fox Corporate Finance GmbH is pleased to publish the new “FCF AUTOMOTIVE SUPPLIER MARKET STUDY – 2021”. Based on available data from European automotive suppliers, the FCF AUTOMOTIVE SUPPLIER MARKET STUDY is a detailed
FCF Valuation Monitor – Q2 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q2 2021”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and
FCF Bank Monitor – Q2 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Bank Monitor – Q2 2021”. FCF regularly engages in research on the banking sector based on available data from the most active and
FCF Life Sciences expands presence in Dubai
FCF Life Sciences cooperating with DACH Advisory Dr. Mathias Schott: “A major step for our clients” Munich, July 7th , 2021 – FCF Life Sciences, a business unit of FCF Corporate Finance GmbH (“FCF”), is
FCF Biotech Venture Capital Monitor – USA 05/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 05/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Bank Monitor – Q1 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Bank Monitor – Q1 2021”. FCF regularly engages in research on the banking sector based on available data from the most active and
FCF Life Sciences Venture Capital Monitor – Europe 05/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 05/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life
IPO plans for magic-mushroom-holding: How good is the new project of German investor Christian Angermayer? | Handelsblatt 10.06.2021 – Quotes by FCF
On Thursday, June 10, the German newspaper “Handelsblatt” reported online and in its print version on the planned IPO of ATAI Life Sciences, a German company specializing in psychedelic drugs. Previously labeled as narcotic drugs,
FCF MedTech & Diagnostics Public Equity Monitor – May 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF MedTech & Diagnostics Public Equity Monitor – May 2021”. The MedTech & Diagnostics Public Equity Monitor, part of FCF Life Sciences Research Series,